Grifols (GIFLF) Change in Cash (2010 - 2025)
Grifols' (GIFLF) quarterly Change in Cash came in at -$180.4 million in Q4 2025, down 738.46% quarter-over-quarter from -$21.5 million in Q4 2023.
Analysis
Grifols (GIFLF) Change in Cash (2010 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Change in Cash for 14 consecutive years, with -$180.4 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Cash changed N/A year-over-year to -$180.4 million; the trailing twelve-month figure through Dec 2025 stood at -$1.6 billion (changed N/A YoY), and the FY2025 full-year result was -$175.1 million, down 136.34% from the prior year.
- Change in Cash retreated to -$180.4 million in Q4 2025 per GIFLF's latest filing, from -$21.5 million in the prior quarter.
- Across five years, Change in Cash topped out at -$21.5 million in Q4 2023 and bottomed at -$2.2 billion in Q4 2022.
- Historically, Change in Cash has averaged -$790.6 million across 3 years, with a median of -$180.4 million in 2025.
- The widest YoY moves for Change in Cash: up 99.01% in 2023, down 99.01% in 2023.
- Over 3 years, Change in Cash stood at -$2.2 billion in 2022, then soared by 99.01% to -$21.5 million in 2023, then plunged by 738.46% to -$180.4 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered -$180.4 million, -$21.5 million, and -$2.2 billion for Q4 2025, Q4 2023, and Q4 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -4.45 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 649.20 Mn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -504.60 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -185.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -170.44 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -180.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -180.43 Mn |
| Dec 31, 2023 | -21.52 Mn |
| Dec 31, 2022 | -2.17 Bn |
| Mar 31, 2020 | 819.10 Mn |
| Dec 31, 2019 | 1.14 Bn |
| Mar 31, 2019 | 1.18 Bn |
| Dec 31, 2018 | 1.01 Bn |
| Jun 30, 2018 | -1.32 Bn |
| Mar 31, 2018 | 1.09 Bn |
| Dec 31, 2017 | 1.84 Bn |
| Jun 30, 2017 | -1.72 Bn |
| Mar 31, 2017 | 1.83 Bn |
| Dec 31, 2016 | -5.89 Mn |
| Sep 30, 2016 | -644.62 Mn |
| Dec 31, 2015 | -135.86 Mn |
| Sep 30, 2015 | -114.69 Mn |
| Jun 30, 2015 | 631.90 Mn |
| Mar 31, 2015 | -317.90 Mn |
| Dec 31, 2014 | 201.78 Mn |
| Sep 30, 2014 | 277.27 Mn |